Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands

被引:27
作者
Maksay, G [1 ]
机构
[1] Hungarian Acad Sci, Chem Res Ctr, Dept Mol Pharmacol, H-1525 Budapest, Hungary
关键词
glycine receptor ionophore complex; strychnine binding; dissociation of strychnine; 5-HT3 receptor ligands; tropeines; allosteric modulation;
D O I
10.1016/S0028-3908(98)00127-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Specific binding of [H-3]strychnine was studied on membranes prepared from rat spinal cord. Several antagonists and agonists of 5-HT3 receptors and tropane derivatives displaced [H-3]strychnine binding with micromolar potencies. In the presence of 10 mu M glycine a high affinity (nanomolar) component of displacement was also observed for the tropeines zatosetron, bemesetron and tropisetron. The displacing potency of glycine was also enhanced by these agents which are therefore termed glycine-positive. In contrast, atropine, SR 57227A, m-chlorophenylbiguanide, metoclopramide and granisetron are termed glycine-negative, because they decreased the displacing potency of glycine while glycine decreased the displacing potencies of atropine and metoclopramide. The dissociation of [H-3]strychnine binding was accelerated in the presence of m-chlorophenylbiguanide, SR 57227A, atropine and zatosetron with a concentration dt dependence (EC50 values and Hill slopes) similar to their displacing effects. This demonstrates that the displacement of strychnine binding is associated with allosteric interactions between different binding sites, Structure-activity analysis revealed that the tropeine structure is essential for high affinity binding, and its substitutions (in scopolamine and cocaine) or its replacement (in ondansetron and metoclopramide) strongly decrease the potency and/or efficacy of allosteric modulation. High affinity modulatory sites for tropeines appear to be associated with the potentiation of ionophore function, but distinct from the low affinity channel blocking sites as well as from the binding sites of strychnine and glycine, (C) 1998 Elsevier Science Ltd. Ail rights reserved.
引用
收藏
页码:1633 / 1641
页数:9
相关论文
共 28 条
[1]   SR-57227A - A POTENT AND SELECTIVE AGONIST AT CENTRAL AND PERIPHERAL 5-HT(3) RECEPTORS IN-VITRO AND IN-VIVO [J].
BACHY, A ;
HEAULME, M ;
GIUDICE, A ;
MICHAUD, JC ;
LEFEVRE, IA ;
SOUILHAC, J ;
MANARA, L ;
EMERIT, MB ;
GOZLAN, H ;
HAMON, M ;
KEANE, PE ;
SOUBRIE, P ;
LEFUR, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 237 (2-3) :299-309
[2]   THE MAMMALIAN GLYCINE RECEPTOR - BIOLOGY AND STRUCTURE OF A NEURONAL CHLORIDE CHANNEL PROTEIN [J].
BETZ, H ;
BECKER, CM .
NEUROCHEMISTRY INTERNATIONAL, 1988, 13 (02) :137-146
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Potentiation of chloride responses to glycine by three 5-HT3 antagonists in rat spinal neurones [J].
ChesnoyMarchais, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :2115-2125
[5]   Interaction of thiocolchicoside with [H-3]strychnine binding sites in rat spinal cord and brainstem [J].
Cimino, M ;
Marini, P ;
Cattabeni, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 318 (01) :201-204
[6]  
FLYNN DD, 1992, MOL PHARMACOL, V41, P736
[7]   5-HT3 RECEPTORS MODULATE SPINAL NOCICEPTIVE REFLEXES [J].
GLAUM, SR ;
PROUDFIT, HK ;
ANDERSON, EG .
BRAIN RESEARCH, 1990, 510 (01) :12-16
[8]  
GREENINGLOH G, 1987, NATURE, V328, P215
[9]   The non-antiemetic uses of serotonin 5-HT3 receptor antagonists - Clinical pharmacology and therapeutic applications [J].
Greenshaw, AJ ;
Silverstone, PH .
DRUGS, 1997, 53 (01) :20-39
[10]   5-HT3 RECEPTORS - PHARMACOLOGICAL AND THERAPEUTIC ASPECTS [J].
GYERMEK, L .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (09) :845-855